DOCUPRENE
-
docusate sodium tablet
Pharmaceutica North America, Inc.
----------
DOCUPRENE 100mgActive Ingredient (in each tablet) Purpose
Sodium Dioctyl Sulfosuccinate 100mg Stool Softner
Each tablet contains 8 mg. of Sodium
Inactive Ingredients
Dicalcium phosphate, microcrystalline cellulose, pregelatinized starch, croscamellose sodium, stearic acid, colloidal silicon dioxide, magnesium sterate, titanium dioxide, talc, hypromellose, polyethylene glycol, FDandC blue #1
Uses:
For the prevention of dry hard stools
For relief of occasional constipation
This product generally produces bowel movement with 12 to 72 hours.
Warnings
Do not use laxative products for longer that one week unless directed to do so by a doctor and if you are presently taking mineral oil, unless told to do so by a doctor.
Ask a doctor before use if you have: Abdominal pain, nausea, vomiting, noticed a sudden change in bowel habits that persists over a period of 2 weeks. Stop use and ask a doctor if: You have rectal bleeding or if you fail to have a bowel movement after use. These could be signs of a serious condition.
If pregnant or breast-feeding , ask a doctor before use.
Other Information
Store at room temperature 68- 77 degrees F
For Questions or Comments
Please email: info pnarx.com
or Call: 877-329-2592
Keep out of reach of children
In case of overdose, get medical help or contact a Poison Control Center right away.
Adults and children 12 years of age and older: Take 1 or 2 tablets daily
Children Under 12 years of age: Do not use, Consult a doctor before use.
NDC 45861-0201-60
DOCUPRENE
100 mg
Sodium Dioctyl Sulfosuccinate
60 Tablets
Made in USA
Patent Pending
Manufactured For
Pharmaceutica North America Glendale CA
DOCUPRENE
docusate sodium tablet |
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
|
Marketing Information | |||
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
OTC monograph not final | part334 | 06/16/2010 |
Labeler - Pharmaceutica North America, Inc. (962739699) |